Stempoint Capital »

Monopar Therapeutics shares owned by Stempoint Capital

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.8M 30k 92.59

More positions owned by Stempoint Capital

Tango Therapeutics (TNGX)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Erasca (ERAS)
Biohaven (BHVN)
Tyra Biosciences (TYRA)
Dianthus Therapeutics (DNTH)
Enliven Therapeutics (ELVN)
Mineralys Therapeutics (MLYS)
Roivant Sciences SHS (ROIV)
Surrozen Com New (SRZN)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Scholar Rock Hldg Corp (SRRK)
Alkermes SHS (ALKS)
First Tracks Biotherapeutics Ord Shs (TRAX)

View all positions for Stempoint Capital

Top funds holding Monopar Therapeutics

Henderson Group
Jupiter Topco
RA Capital Management
BlackRock
Deerfield Management Company
Saturn V Capital Management
Siren
ADAR1 Capital Management
Polar Capital Holdings
Vanguard Capital Management
Adage Capital Partners GP
TCG Crossover Management
Wellington Management Company
OrbiMed Advisors
Candriam Luxembourg S.C.A.

View all funds holding Monopar Therapeutics